Carnival Corporation & plc · CCL · FY2026 Q2 · Calendar Q2 2026
Carnival Q2 2026: Record Yields and Earnings Offset by Geopolitical Yield Cut
Carnival delivered record second-quarter results with all-time-high yields, EBITDA, and net income, beating EPS estimates by 19%. The market reacted negatively, however, as management trimmed yield guidance by 100 basis points citing Middle East geopolitical volatility affecting European itineraries. The stock fell 3.4% on the report day versus a 1.5% benchmark decline and drifted a further 9.1% lower over subsequent sessions. Management raised overall full-year guidance and characterized the yield dip as transitory, with 2027 bookings running ahead of last year. The completion of the dual-listed company unification, continued share repurchases, and a ten-vessel newbuild pipeline reinforce management's confidence in long-term pricing power, but near-term geopolitical uncertainty has tempered investor reception.
Company context
Snapshot as of publicationCarnival Corporation & plc operates as a prominent global entity in the leisure travel sector. Its extensive fleet of vessels navigates to nearly 700 different ports globally, sailing under a diverse portfolio of acclaimed brands such as Carnival Cruise Line, Princess Cruises, Holland America Line, P&O Cruises (Australia), Seabourn, Costa Cruises, AIDA Cruises, P&O Cruises (UK), and Cunard. Beyond its core cruise operations, the company also provides port services and other related offerings. Its holdings include and it manages hotels, lodges, unique glass-domed railcars, and motor coaches.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | Hold | Maintain | Jul 23, 2026 |
| Tigress Financial | Buy | Buy | Maintain | Jun 30, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jun 25, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jun 24, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jun 24, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 16, 2026 |
| Stifel | Buy | Buy | Maintain | Jun 12, 2026 |
| TD Cowen | Buy | Buy | Maintain | May 15, 2026 |
| UBS | Buy | Buy | Maintain | Apr 13, 2026 |
| HSBC | Buy | Hold | Upgrade | Mar 30, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Mar 30, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Mar 27, 2026 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Mar 19, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Mar 11, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jan 12, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Dec 22, 2025 |
| Argus Research | Buy | Buy | Maintain | Dec 22, 2025 |
| Jefferies | Buy | Buy | Maintain | Dec 15, 2025 |
| Melius Research | Buy | Buy | Maintain | Sep 15, 2025 |
| JP Morgan | Overweight | Overweight | Maintain | Sep 15, 2025 |
| Loop Capital | Hold | Hold | Maintain | Jun 3, 2025 |
| Macquarie | Outperform | Outperform | Maintain | May 9, 2025 |
| Redburn Partners | Buy | Neutral | Upgrade | Sep 14, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Mar 28, 2023 |
| Berenberg | Hold | Sell | Upgrade | Oct 21, 2021 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jun 16, 2021 |
| Redburn | Neutral | Buy | Downgrade | Jun 22, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 20, 2020 |
| CFRA | Sell | Sell | Maintain | Apr 14, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 8, 2020 |
| Wedbush | Neutral | Neutral | Maintain | Dec 23, 2019 |
| Standpoint Research | Buy | Hold | Upgrade | Dec 23, 2019 |
| Buckingham Research | Neutral | Neutral | Maintain | Oct 2, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Oct 2, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Sep 27, 2019 |
| Argus | Hold | Buy | Downgrade | Jul 6, 2018 |
| William Blair | Outperform | Market Perform | Upgrade | Mar 21, 2017 |
| Sterne Agee CRT | Buy | Buy | Maintain | Jun 7, 2016 |
| Numis Securities | Buy | Hold | Upgrade | Mar 30, 2015 |
| Natixis | Neutral | Buy | Downgrade | Jan 12, 2015 |
| Bank of America | Buy | Buy | Maintain | Dec 5, 2014 |
| Shore Capital | Buy | Hold | Upgrade | Sep 12, 2014 |
| Exane BNP Paribas | Underperform | Neutral | Downgrade | May 30, 2013 |
| RS Platou Markets | Neutral | Neutral | Maintain | May 21, 2013 |
| Topeka Capital | Hold | Buy | Downgrade | Sep 24, 2012 |
| Topeka | Hold | Buy | Downgrade | Sep 24, 2012 |
| Charles Stanley | Hold | Accumulate | Downgrade | Feb 8, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $27.81. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BMO Capital | Tristan Thomas-Martin | $30 | $26.68 | +7.9% | Jul 7, 2026 |
| Tigress Financial | Ivan Feinseth | $42 | $28.57 | +51.0% | Jun 30, 2026 |
| Argus Research | Analyst unavailable | $35 | $28.84 | +25.9% | Jun 26, 2026 |
| Susquehanna | Analyst unavailable | $33 | $28.72 | +18.7% | Jun 24, 2026 |
| Barclays | Analyst unavailable | $35 | $28.72 | +25.9% | Jun 24, 2026 |
| Melius Research | Analyst unavailable | $36 | $30.85 | +29.4% | Jun 17, 2026 |
| Stifel Nicolaus | Steven Wieczynski | $36 | $28.12 | +29.4% | Jun 12, 2026 |
| Loop Capital Markets | Analyst unavailable | $36 | $28.06 | +29.4% | Jun 1, 2026 |
| Wells Fargo | Analyst unavailable | $36 | $28.69 | +29.4% | Apr 15, 2026 |
| Mizuho Securities | Analyst unavailable | $39 | $24.19 | +40.2% | Mar 27, 2026 |
| Truist Financial | Analyst unavailable | $34 | $28.21 | +22.3% | Jan 22, 2026 |
| UBS | Robin Farley | $38 | $31.7 | +36.6% | Jan 12, 2026 |
| Morgan Stanley | Jamie Rollo | $33 | $31.88 | +18.7% | Jan 7, 2026 |
| Bernstein | Analyst unavailable | $33 | $32.27 | +18.7% | Jan 6, 2026 |
| Deutsche Bank | Analyst unavailable | $34 | $31.92 | +22.3% | Dec 22, 2025 |
| Mizuho Securities | Analyst unavailable | $38 | $31.12 | +36.6% | Dec 22, 2025 |
| Truist Financial | Patrick Scholes | $31 | $31.92 | +11.5% | Dec 22, 2025 |
| Stifel Nicolaus | Steven Wieczynski | $40 | $31.12 | +43.8% | Dec 22, 2025 |
| Goldman Sachs | Lizzie Dove | $34 | $31.12 | +22.3% | Dec 22, 2025 |
| Wells Fargo | Trey Bowers | $38 | $31.12 | +36.6% | Dec 22, 2025 |
| UBS | Analyst unavailable | $37 | $28.12 | +33.0% | Dec 18, 2025 |
| Barclays | Analyst unavailable | $36 | $28.2 | +29.4% | Dec 17, 2025 |
| Deutsche Bank | Analyst unavailable | $33 | $28.76 | +18.7% | Dec 16, 2025 |
| Susquehanna | Analyst unavailable | $40 | $28.6 | +43.8% | Dec 16, 2025 |
| Jefferies | Analyst unavailable | $37 | $27.62 | +33.0% | Dec 15, 2025 |
| Wells Fargo | Trey Bowers | $35 | $27.86 | +25.9% | Dec 12, 2025 |
| Tigress Financial | Analyst unavailable | $40 | $28.97 | +43.8% | Oct 15, 2025 |
| UBS | Analyst unavailable | $35 | $28.91 | +25.9% | Oct 1, 2025 |
| Susquehanna | Analyst unavailable | $35 | $29.4 | +25.9% | Sep 30, 2025 |
| Mizuho Securities | Ben Chaiken | $37 | $30.14 | +33.0% | Sep 25, 2025 |
| Stifel Nicolaus | Steven Wieczynski | $38 | $30.71 | +36.6% | Sep 23, 2025 |
| Barclays | Analyst unavailable | $37 | $31.19 | +33.0% | Sep 17, 2025 |
| Stifel Nicolaus | Analyst unavailable | $34 | $25.48 | +22.3% | Jun 25, 2025 |
| Truist Financial | Patrick Scholes | $27 | $23.77 | -2.9% | Jun 23, 2025 |
| Tigress Financial | Ivan Feinseth | $32 | $21.02 | +15.1% | Mar 26, 2025 |
| Morgan Stanley | Jamie Rollo | $22 | $23.84 | -20.9% | Jan 8, 2025 |
| Truist Financial | Patrick Scholes | $29 | $26.38 | +4.3% | Dec 2, 2024 |
| Deutsche Bank | Chris Woronka | $19 | $18.02 | -31.7% | Oct 4, 2024 |
| Truist Financial | Patrick Scholes | $20 | $17.84 | -28.1% | Oct 1, 2024 |
| Morgan Stanley | Jamie Rollo | $16.5 | $18.48 | -40.7% | Oct 1, 2024 |
| Bank of America Securities | Andrew Didora | $24 | $18.97 | -13.7% | Sep 24, 2024 |
| Stifel Nicolaus | Steven Wieczynski | $27 | $18.76 | -2.9% | Sep 20, 2024 |
| Argus Research | John Staszak | $25 | $18.61 | -10.1% | Jun 27, 2024 |
| Macquarie | Paul Golding | $25 | $18.42 | -10.1% | Jun 26, 2024 |
| Wolfe Research | Greg Badishkanian | $19 | $17.82 | -31.7% | Jun 25, 2024 |
| Morgan Stanley | Jamie Rollo | $13.5 | $17.82 | -51.5% | Jun 25, 2024 |
| Truist Financial | Patrick Scholes | $17 | $15.65 | -38.9% | May 29, 2024 |
| CFRA | Siye Desta | $19 | $16.37 | -31.7% | Apr 1, 2024 |
| UBS | Robin Farley | $20 | $16.54 | -28.1% | Apr 1, 2024 |
| Argus Research | John Staszak | $20 | $16.34 | -28.1% | Apr 1, 2024 |
| Stifel Nicolaus | Steven Wieczynski | $25 | $17.19 | -10.1% | Mar 28, 2024 |
| Goldman Sachs | Analyst unavailable | $22 | $17.19 | -20.9% | Mar 28, 2024 |
| Macquarie | Analyst unavailable | $24 | $17.19 | -13.7% | Mar 27, 2024 |
| Mizuho Securities | Ben Chaiken | $21 | $16.88 | -24.5% | Mar 26, 2024 |
| Stifel Nicolaus | Steven Wieczynski | $26 | $17.2 | -6.5% | Mar 25, 2024 |
| Goldman Sachs | Lizzie Dove | $20 | $16.65 | -28.1% | Mar 13, 2024 |
| Wells Fargo | Daniel Politzer | $22 | $17.33 | -20.9% | Jan 5, 2024 |
| Argus Research | John Staszak | $21 | $14.44 | -24.5% | Sep 29, 2023 |
| Jefferies | David Katz | $25 | $17.16 | -10.1% | Jun 30, 2023 |
| Citigroup | James Hardiman | $18 | $15.52 | -35.3% | Jun 27, 2023 |
| Wells Fargo | Daniel Politzer | $9 | $9.34 | -67.6% | Mar 28, 2023 |
| Truist Financial | Analyst unavailable | $10 | $10.8 | -64.0% | Sep 20, 2022 |
| Stifel Nicolaus | Steven Wieczynski | $20 | $9.69 | -28.1% | Aug 3, 2022 |
| Barclays | Brandt Montour | $14 | $8.86 | -49.7% | Jun 29, 2022 |
| Deutsche Bank | Chris Woronka | $14 | $10.55 | -49.7% | Jun 28, 2022 |
| Morgan Stanley | Jamie Rollo | $13 | $9.6 | -53.3% | Jun 18, 2022 |
| Stifel Nicolaus | Steven Wieczynski | $30 | $17.41 | +7.9% | Apr 27, 2022 |
| Citigroup | James Hardiman | $22 | $19.04 | -20.9% | Apr 19, 2022 |
| Jefferies | David Katz | $19 | $20.05 | -31.7% | Apr 1, 2022 |
| Berenberg Bank | Stuart Gordon | $23 | $21.98 | -17.3% | Jan 18, 2022 |
| Goldman Sachs | Stephen Grambling | $21 | $20.54 | -24.5% | Dec 21, 2021 |
| Credit Suisse | Benjamin Chaiken | $38 | $20.54 | +36.6% | Dec 21, 2021 |
| Bank of America Securities | Andrew Didora | $29 | $18.5 | +4.3% | Dec 7, 2021 |
| HSBC | Ali Naqvi | $18.3 | $21.66 | -34.2% | Aug 19, 2021 |
| J.P. Morgan | Brandt Montour | $36 | $28.42 | +29.4% | Jun 17, 2021 |
| Macquarie | Paul Golding | $32 | $25.72 | +15.1% | Apr 20, 2021 |
Track every rating change on CCL the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session closeFollow CCL with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Q2 2026 delivered record revenue, yields, EBITDA, and net income. EPS came in at $0.41 versus an estimated $0.3442, a 19.1% surprise. Revenue was $6.663 billion, slightly below the $6.687 billion estimate (-0.4%). Cost discipline was notable: cruise costs ex-fuel were flat year-over-year, outperforming guidance by 2.5 points. Management raised full-year guidance overall but cut the yield growth line by 100 basis points due to Middle East conflict affecting European deployments, while emphasizing the impact is transitory and expected to reverse in the second half. Three new Princess Cruises ships were ordered for delivery in 2035, 2038, and 2039, bringing the total order book to ten vessels. The dual-listed company structure was unified into a single global share price, simplifying the corporate structure. The stock fell 3.4% on the day (versus a -1.5% benchmark move) on volume 1.6x baseline, with a further 9.1% decline in subsequent sessions.
Guidance delta
Full-year guidance was raised overall, reflecting strong second-half expectations. However, yield growth guidance was reduced by 100 basis points due to geopolitical volatility in the Middle East affecting European itineraries. Management characterized the impact as transitory and expects a reversal in the second half. Cost guidance outperformed by 2.5 points with flat cruise costs ex-fuel. Guidance sentiment is raised with management tone described as confident.
Key takeaways
- Record Q2 results: yields, EBITDA, and net income all at all-time highs, with EPS beating estimates by 19%.
- Cost discipline: flat cruise costs ex-fuel, a 2.5-point outperformance versus guidance.
- Yield guidance trimmed 100 bps due to Middle East conflict, but management expects a second-half reversal.
- 2027 bookings remain ahead of last year, signaling demand durability beyond the current geopolitical headwind.
- Three new Princess Cruises ships ordered for 2035, 2038, and 2039, extending the order book to ten vessels.
- Dual-listed company unification completed, simplifying the corporate structure and creating a single global share price.
Management priorities
- Continue fleet modernization through AIDA Evolution and Holland America Evolution programs.
- Expand destination portfolio including Celebration Key development, RelaxAway Half Moon Cay pier, and Isla Tropicale.
- Maintain disciplined share buybacks and pursue modest dividend increases.
- Deliver three new Princess Cruises ships across 2035, 2038, and 2039.
- Leverage enhanced commercial capabilities in revenue management, personalization, and marketing to drive yield growth.
Sources
- Earnings call transcript and parsed analysis · 2026-06-23T17:11:05.716105+00:00
- FN2 earnings calendar · 2026-07-29T01:23:15.868211+00:00
- Polygon adjusted daily market bars · 2026-07-30T06:21:22.384049+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T06:21:22.381317+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.